Niki BioSolutions, Inc. Deferred Tax Assets, Valuation Allowance
Niki BioSolutions, Inc. (NIKI) had Deferred Tax Assets, Valuation Allowance of $15.99 million as of 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-05-11
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $15.99M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $15.77M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $17.41M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $15.71M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2025-12-31 | $15.99M S-4/A · filed 2026-05-11 |
| 2024-12-31 | $15.77M S-4/A · filed 2026-05-11 |
| 2023-12-31 | $17.41M S-4/A · filed 2026-05-11 |
| 2022-12-31 | $15.71M S-4/A · filed 2026-05-11 |
| 2021-12-31 | $12.63M 6-K · filed 2025-10-08 |
| 2020-12-31 | $9.56M 20-F · filed 2024-04-30 |
| 2019-12-31 | $6.15M 20-F · filed 2023-04-28 |
| 2018-12-31 | $3.05M 20-F/A · filed 2023-01-17 |
| 2017-12-31 | $999.62K 20-F · filed 2019-04-15 |